New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 30, 2014
07:51 EDTNLNKNewLink Genetics price target raised to $40 from $23 at RW Baird
Baird raised its price target on NewLink Genetics on expectations of a fairly strong and aggressive uptake of IDO-inhibitor indoximod for many types of cancer. Shares are Outperform rated.
News For NLNK From The Last 14 Days
Check below for free stories on NLNK the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for NLNK

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use